AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
Health FacilitiesProgram EvaluationSkilled Nursing FacilitiesEarly Detection of CancerProgram DevelopmentUnited StatesResidential FacilitiesBreast NeoplasmsProstatic NeoplasmsGovernment ProgramsOvarian NeoplasmsLung NeoplasmsAmbulatory Care FacilitiesQuestionnairesNeoplasmsStomach NeoplasmsColonic NeoplasmsFacility Design and ConstructionRetrospective StudiesNeoplasm MetastasisNeoplasm InvasivenessFollow-Up StudiesNational Health ProgramsPancreatic NeoplasmsUterine Cervical NeoplasmsProspective StudiesGene Expression Regulation, NeoplasticAssisted Living FacilitiesMice, NudeCancer VaccinesRisk FactorsHealth Facility AdministrationRisk AssessmentSurvival AnalysisHealth Facilities, ProprietaryHealth PromotionAge FactorsSurvival RateNeoplasm ProteinsRegistriesGene Expression ProfilingPrognosisRiskHealth Facility PlanningPublic FacilitiesHealth Services AccessibilityNational Cancer Institute (U.S.)Health EducationGenetic Predisposition to DiseaseTreatment OutcomeLong-Term CareReverse Transcriptase Polymerase Chain ReactionAntineoplastic AgentsDisease ProgressionFacility Regulation and ControlColorectal NeoplasmsSmokingAntineoplastic Combined Chemotherapy ProtocolsPilot ProjectsTime FactorsCarcinomaOdds RatioCarcinoma, Squamous CellMutationSensitivity and SpecificityCell Line, TumorLogistic ModelsDrug Resistance, NeoplasmRNA, MessengerCarcinoma, Non-Small-Cell LungUrinary Bladder NeoplasmsSoftwareMultivariate AnalysisSEER ProgramCross-Sectional StudiesSurvivorsMammographyCommunity Health ServicesReproducibility of ResultsNursing HomesIncidenceReceptors, EstrogenNeoplasm StagingXenograft Model Antitumor AssaysTumor Markers, BiologicalManaged Care ProgramsCombined Modality TherapyPrevalenceCost-Benefit AnalysisMedical OncologyCaliforniaReceptor, erbB-2Quality of LifeBlotting, WesternGenotypeImmunization ProgramsRectal NeoplasmsOligonucleotide Array Sequence AnalysisNeoplasm Recurrence, LocalJapan